Martyno Lab - Company finances
|
EUR
|
2020
From: 2020-10-09
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-31
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 8,612 | 46,282 | 39,040 | 39,135 | 59,675 | 59,369 |
| Profit before tax | 7,521 | 12,236 | -5,502 | 4,860 | 26,224 | 7,892 |
| Net profit | 7,521 | 12,852 | -5,502 | 4,617 | 24,811 | 7,357 |
| Equity | 7,527 | 19,148 | 13,645 | 18,262 | 43,073 | 50,430 |
| Liabilities | - | - | 774 | 1,037 | 1,903 | 998 |
| Non-current assets | 0 | 1,181 | 675 | 1,117 | 19,367 | 17,355 |
| Current assets | 8,618 | 18,806 | 13,744 | 18,182 | 25,609 | 34,073 |
| Total assets | 8,618 | 19,987 | 14,419 | 19,299 | 44,976 | 51,428 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 2,400 | 2,638 | 2,481 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +437.4% | -15.6% | +0.2% | +52.5% | -0.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 87.3% | 64.3% | -38.2% | 23.9% | 55.2% | 14.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.9% | 67.1% | -40.3% | 25.3% | 57.6% | 14.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 87.3% | 27.8% | -14.1% | 11.8% | 41.6% | 12.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 87.3% | 26.4% | -14.1% | 12.4% | 43.9% | 13.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Martyno Lab - Social security debts
The amount of overdue SODRA debt for the company Martyno Lab as of the last working day is: 481 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-14 | 2026-09-15 | 481.22 |
| 2026-09-05 | 2026-09-13 | 337.71 |
| 2026-09-01 | 2026-09-02 | 337.71 |
| 2026-08-26 | 2026-08-31 | 257.23 |
| 2026-08-23 | 2026-08-23 | 257.23 |
| 2026-08-19 | 2026-08-19 | 257.23 |
| 2026-08-16 | 2026-08-17 | 257.23 |
| 2026-08-07 | 2026-08-14 | 257.23 |
| 2026-08-01 | 2026-08-06 | 177.50 |
| 2026-07-24 | 2026-07-31 | 97.02 |
| 2026-07-14 | 2026-07-23 | 577.63 |
| 2026-07-07 | 2026-07-13 | 497.90 |
| 2026-07-01 | 2026-07-06 | 532.50 |
| 2026-06-11 | 2026-06-30 | 452.02 |
| 2026-06-02 | 2026-06-10 | 355.00 |
| 2026-05-13 | 2026-06-01 | 274.52 |
| 2026-05-11 | 2026-05-12 | 177.50 |
| 2026-05-04 | 2026-05-10 | 80.48 |
| 2026-05-03 | 2026-05-03 | 257.98 |
| 2026-04-15 | 2026-04-30 | 177.50 |
| 2026-04-01 | 2026-04-14 | 80.48 |
| 2026-03-15 | 2026-03-31 | 97.02 |
| 2026-03-03 | 2026-03-14 | 93.25 |
| 2026-02-13 | 2026-03-02 | 12.77 |
| 2023-07-19 | 2023-07-31 | 1646.79 |
Martyno Lab - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Martyno Lab is: 173 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-12 | 2026-09-02 | 172.95 |
| 2026-07-16 | 2026-07-26 | 173.7 |
| 2026-07-02 | 2026-07-15 | 0.75 |
| 2026-06-18 | 2026-07-01 | 345.9 |
| 2026-02-18 | 2026-03-08 | 172.95 |
| 2026-01-13 | 2026-01-22 | 150.0 |
| 2025-12-15 | 2025-12-18 | 150.0 |
| 2025-11-14 | 2025-11-25 | 150.0 |
| 2025-10-15 | 2025-10-22 | 150.0 |
| 2025-09-16 | 2025-10-05 | 150.0 |
| 2025-08-19 | 2025-08-25 | 150.0 |
| 2025-07-16 | 2025-07-25 | 118.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Martyno Lab, MB (code 305638611) is a small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €59.4K and net profit of €7.4K, which corresponds to a profit margin of 12.4%. Revenue was broadly stable year on year, with a slight decline of 0.5% from 2024, while the two-year comparison still shows solid growth of 51.7% versus 2023. Profitability was much higher in 2024, when net profit reached €24.8K on revenue of €59.7K, after €4.6K in 2023. The 2025 balance sheet remained very strong, with total assets of €51.4K, equity of €50.4K and liabilities of just €998. This leaves an equity ratio of 98.1% and a debt-to-equity ratio of 0.02. Return on equity was 14.6% and return on assets 14.3%, while asset turnover stood at 1.15x, indicating efficient use of the asset base.